Security key
14757U109
- Security type / class
- Equity / COM
- Total 13F shares
- 21,739,166
- Total 13F value
- $44,345,565
- Share change
- +1,292,259
- SEC-reported price per share
- $2.04
- Number of holders
- 55
- Value change
- +$2,549,424
- Number of buys
- 29
- Number of sells
- 18
Report period
Q1 2020
Institutions
55
Top holders
10
CASI full security history
Ownership snapshot
Full 13F holder table
CASI Pharmaceuticals, Inc. SEC filings
CASI Pharmaceuticals, Inc. company facts
Broader feeds
Ownership snapshot
Top reported holders of CASI - CASI PHARMACEUTICALS INC - COM (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.
Comparable stake leader
IDG-Accel China Growth Fu...
Disclosed value leader
IDG-Accel China Growth Fu...
Comparable rows
0/15
Latest evidence
31 Dec 2019
13F
Highest disclosed value: $24,638,000
15 rows are not safely comparable across share classes.
Showing 1-6 of 15 holder rows.
Quick read
IDG-Accel China Growth Fund III Associates L.P. has the largest disclosed position value at $24.64M.
0 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.
Open SEC evidence
Opens IDG-Accel China Growth Fund III Associates L.P.'s linked filing trail.
Disclosed position value
Top 5
IDG-Accel China Growth Fund III A...
$24.64M
BlackRock Finance, Inc.
$10.15M
VANGUARD GROUP INC
$7.22M
Wellington Shields Capital Manage...
$4.06M
Wellington Shields & Co., LLC
$3.95M
Value bars compare disclosed positions; verify each figure against the linked filing evidence.
Detailed SEC evidence table Showing 1-6 of 15 holder rows
| Holder | Evidence | Ownership % | Position | 12M Net Δ | As of |
|---|---|---|---|---|---|
| IDG-Accel China Growth Fund III Associates L.P. |
13F
Company
|
—
denominator unverified
|
$24,638,000
7,973,536 shares
|
— | 31 Dec 2019 |
| BlackRock Finance, Inc. |
13F
Company
|
—
denominator unverified
|
$10,151,000
3,285,147 shares
|
— | 31 Dec 2019 |
| VANGUARD GROUP INC |
13F
Company
|
—
denominator unverified
|
$7,217,000
2,335,486 shares
|
— | 31 Dec 2019 |
| Wellington Shields Capital Management, LLC |
13F
Company
|
—
denominator unverified
|
$4,065,000
1,315,577 shares
|
— | 31 Dec 2019 |
| Wellington Shields & Co., LLC |
13F
Company
|
—
denominator unverified
|
$3,947,000
1,277,322 shares
|
— | 31 Dec 2019 |
| STATE STREET CORP |
13F
Company
|
—
denominator unverified
|
$2,940,000
951,326 shares
|
— | 31 Dec 2019 |
How to read this table
Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
13F holder rows
Institutional holders as of Q1 2020
Investor-level positions for this CUSIP, loaded as an interactive table.
Institutions
55
Shares
21,739,166
Rows available
55
| Investor | Option | Weight % | Change % | SEC-reported value | * Price | Shares | Share Change | Activity | Report Period |
|---|
* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.
Compare Q1 2020 vs Q1 2020 Across Filers
Q1 2020 holders
55
Q1 2020 holders
55
Holder diff
0
| Investor | Q1 2020 Shares | Q1 2020 Shares | Share Diff | Share Chg % | Q1 2020 value | Q1 2020 value | Value change | Value Chg % |
|---|